Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 264INDUSTRY 159NIH 27OTHER_GOV 4NETWORK 4FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1Leukemia 1

Interventions

Clofarabine 2zanubrutinib 1venetoclax 1talabostat 1ibrutinib 1acalabrutinib 1Topotecan 1Tablets 1Rituximab 1PT-100 dipeptide 1Mitoxantrone 1Midazolam 1Ketamine 1Exercise 1Etoposide 1Dosage Forms 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Azacitidine × Other hematologic neoplasm × Clear all
NCT00728520 2008-08-06

Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy

Kansas City Veteran Affairs Medical Center

Phase 2 Unknown
40 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡